SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
3.50
Ask:
4.00
Spread: 0.50 (14.286%)
Market Cap: £1.04m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Trading Statement

29 May 2014 07:00

RNS Number : 2865I
Sabien Technology Group PLC
29 May 2014
 



Sabien Technology Group plc

("Sabien" or "the Company")

Trading Update

The Board of Sabien Technology Group plc (AIM: SNT), the manufacturer and supplier of M2G, an energy efficiency technology, announces that, in light of recently delayed orders, the Company now expects to report a loss of up to c.£0.3m in the financial year to June 30 2014.

The shortfall in revenue relative to management expectations is due to a delay in the receipt of some substantial customer orders that were expected to be received in the second half of the financial year but which now are expected in the first half of the next financial year.

In line with management expectations administrative expenses for the current financial year are c.£0.5m higher than last year due primarily to the increase in Business Development Manager headcount but also the investment in the indirect channel for overseas development, the move to larger offices and the expenditure on new product development.

The investment made in new Business Development Managers in the first half of this financial year is beginning to produce returns as a number of sales pipeline opportunities are now maturing into orders. The Company is also continuing to expand its overseas distribution network and since February 2014 has added M2G distributors in China, Greece, Pakistan, Iran, UAE, Spain, Israel, Australasia and South Africa. To date we have received initial small orders from these distributors and we expect further growth in both the size of future orders and the number of distributors in the next year. The sales pipeline currently stands at £5.8m which compares with £6.6m at the time of the February trading update and £4.6m as at 30 June 2013.

During the current financial year, the Company has developed a new product for use on hot water calorifiers (small water heaters) which have been previously too small to install an M2G. Based on the analysis of previous roll-outs of M2G, the Company estimates that these calorifiers could represent up to 20% of all the boilers on a typical estate. Results of 'infield' client trials have proven that considerable savings can be made and, as a consequence, we will be launching this new product later in the calendar year.

Despite the delays in orders received, the Company expects to start the new financial year on 1 July 2014 with an order book of at least £0.5m and this, alongside the potential for new revenue sources from the new product and from our overseas distribution network as well as the growth in the existing sales pipeline, gives the Board confidence in the Company's growth prospects.

The Company's net cash position remains strong and, despite the loss forecast for the year, is expected to be at least at the same level at 30 June 2014 as it was at 30 June 2013 (£1.36m). The reason is due to the reduction in working capital over the period.

The Board believes that Sabien has sufficient capital to execute its business plan and deliver the anticipated growth in the years ahead. As a result of the strong cash position and the expectation that work on the delayed orders will commence in the second half of the calendar year, the Board expects to be in a position to continue with its progressive dividend policy following the maiden dividend announced in 2013.

A further trading update will be provided to the market after the end of the current financial year.

Commenting on trading, Alan O'Brien, Chief Executive of Sabien said:

"Although the reduction in revenue this year has been a source of frustration for the management team and me, there have not been any contract cancellations, only delays in the placing of orders.

This year has seen material progress in a number of areas. We have broadened our business development capabilities, signed commercial M2G distribution agreements in Europe, Middle East, Asia and Australasia, and developed and piloted a new product for hot water calorifiers which we intend to launch later in 2014. This is expected to lead to a wider application of our products in our target markets.

I am confident that Sabien's prospects for the medium and long-term remain positive and there is still a substantial market opportunity to create a profitable and valuable business moving forward."

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFSRELITFIS
Date   Source Headline
16th Aug 20227:00 amRNSExtension of Sales Agency Agreement
5th Aug 20225:15 pmRNSNotice of GM & Holdings in the Company
4th Aug 20227:00 amRNSOversubscribed Broker Option to raise £100,000
3rd Aug 20227:00 amRNSPlacing to raise £500,000 & Broker Option
8th Jul 202212:45 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update
7th Jun 20227:00 amRNSHolding(s) in Company
13th May 20227:00 amRNSWelsh Freeport
5th May 20227:00 amRNSUpdate on b.grn
11th Apr 20221:00 pmRNSCorporate Update - Contract Win
4th Apr 20225:00 pmRNSProject COFFEE - Replacement
4th Apr 20222:30 pmRNSProject COFFEE
31st Mar 20224:02 pmRNSHalf-year Report
31st Mar 20227:00 amRNSHolding(s) in Company
25th Mar 20227:00 amRNSContract Win
3rd Feb 20222:03 pmRNSHolding(s) in Company
2nd Feb 20227:00 amRNSMOU signed with Irish Renewable Fuels Ltd.
1st Feb 20222:43 pmRNSLicence agreement with Proton Technologies Canada
18th Jan 20227:00 amRNSChanges to Warrant Terms
14th Jan 20224:25 pmRNSHolding(s) in Company
31st Dec 202112:00 pmRNSTotal Voting Rights
22nd Dec 20217:00 amRNSAgreement for Establishment of SPV
26th Nov 20217:00 amRNSWarrant Exercise
11th Nov 20217:00 amRNSLicence agreement with Proton Technologies
4th Nov 20217:00 amRNSRole of Carbon Credits, Blockchain & Carbon Market
1st Nov 20217:00 amRNSCOP26: Sabien hosts Green Economics Debate
29th Oct 20215:00 pmRNSTotal Voting Rights
14th Oct 20213:00 pmRNSResult of AGM
14th Oct 202110:00 amRNSSabien Presentation at FTE Mykonos
14th Oct 20218:00 amRNSIssue of Equity
14th Oct 20217:30 amRNSAGM Statement
14th Oct 20217:00 amRNSSubscription and possible Co-operation Agreement
21st Sep 20217:00 amRNSHolding(s) in Company
16th Sep 20211:02 pmRNSAeristech: Investor Update
16th Sep 202111:30 amRNSHolding(s) in Company
15th Sep 20217:00 amRNSSales Agency Agreement
14th Sep 20216:00 pmRNSPosting of Annual Report & Notice of AGM
31st Aug 20217:12 amRNSFinal Results for the year to 30 June 2021
31st Aug 20217:00 amRNSFinal Results for the Year to 30 June 2021
10th Aug 202112:12 pmRNSHolding(s) in Company
7th Jul 20217:00 amRNSTrading Update
25th Jun 202111:15 amRNSOperational Update
18th Jun 20217:00 amRNSAppointment of Chief Scientific Officer
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:36 pmRNSPrice Monitoring Extension
31st Mar 20215:00 pmRNSTotal Voting Rights
29th Mar 20213:45 pmRNSResult of AGM
25th Mar 20217:00 amRNSHalf-year Report
19th Mar 20218:45 amRNSHolding(s) in Company
11th Mar 20214:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.